Rare diseases
Investigational molecules
Locations
Study of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
BelgiumStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
BelgiumStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
BelgiumStudy of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria
BelgiumStudy of inhaled interferon beta-1a (SNG001) for treatment of patients with viral lower respiratory tract infections who require mechanical ventilation
BelgiumStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
BelgiumLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
BelgiumStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
BelgiumStudy of VS-01 with different treatment times compared to standard care alone in patients with overt hepatic encephalopathy and liver cirrhosis complications
BelgiumStudy of ALKS 2680 to treat excessive daytime sleepiness in people with idiopathic hypersomnia
BelgiumStudy of BI 765423 given by intravenous infusion for patients with idiopathic pulmonary fibrosis with or without standard treatment
BelgiumComparing diclofenac sodium eye drops versus dexamethasone phosphate eye drops for recovery after vitrectomy in patients with macular disorders
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
